Document is current

Any future updates will be listed below

Biological toxicities as surrogate markers of efficacy in patients treated with mTOR inhibitors for metastatic renal cell carcinoma

Crossref DOI link: https://doi.org/10.1186/s12885-016-2993-7

Published Online: 2017-01-06

Published Print: 2017-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark